Delivery Order 75N93018D00011-75N93023F00001
Award Date
9/26/23
Potential Completion Date
5/14/28
Potential Value
$24M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
IDT Biologika GMBH
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a German biotechnology company. The $1,366,000 contract is for the development, manufacturing, and characterization of various biological materials to support infectious disease research and pandemic preparedness efforts, including influenza virus human challenge material, Staphylococcus aureus...
This is a federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract, valued at a ceiling of $2,723,700.00, is for vaccine manufacturing and characterization services to support infectious disease research and pandemic preparedness efforts. Specific work includes the development,...
This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $555,600.00 contract was awarded to IDT Biologika GMBH, a German biotechnology company, for the development and manufacture of toxoid fusion proteins and master cell banks. The contract has a total ceiling value of $1,693,261.00 and is a delivery order with a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The $20,462.00 fixed-price delivery order contract is for process development of vaccine candidates, including for SARS-CoV-2. This contract is not associated with any set-aside designations. IDT Biologika GMBH has been awarded multiple prime federal contracts by NIAID for...
This is a prime contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to IDT Biologika GMBH, a German biotechnology company. The $1,149,011.00 firm fixed price contract is for process development and master bank production of a Staphylococcus aureus protein A product. This work supports NIAID's infectious disease research and pandemic preparedness...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Fraunhofer USA, Inc. for the development of influenza virus-like particles in a plant-based system. The contract has a ceiling value of $364,793 and a period of performance that ends on March 29, 2017. The contract was not set aside for a specific business type. Fraunhofer USA, Inc. is the...
This federal contract award with ID 75N91019D00024|75N91023F00008 was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The objective of this $292,634,066.00 cost-plus-fixed-fee delivery order task order is to support NIAID's goal of conducting a series of standardized Phase 1 and Phase 2 clinical trials on next-generation vaccines to generate data to inform decisions on which candidates to advance...
This federal contract award, with an ID of 75N93019D00002|75N93022F00001, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $3,266,305.22 delivery order was awarded to the American Type Culture Collection (ATCC), a non-profit organization that provides biological materials and services to government, academic, and industry customers. The contract is for the production of well-characterized...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI) to manufacture influenza virus human challenge material for Phase I and II clinical testing. The contract has a ceiling value of $8,337,685.00 and runs through December 31, 2025. IAVI, a global non-profit organization focused on developing preventive HIV vaccines, will serve as the...
This is a $18,576,013.05 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to the nonprofit research institute Access To Advanced Health Institute (AAHI), also known as Aahi, Idri, and Infectious Disease Research Institute. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant (AMR) infections, and emerging infectious...